Director Out As Sigma Xi Ponders Role

BOSTON—The executive director of Sigma Xi, one of the nation's oldest and most prestigious scientific societies, has been forced out in a bitter dispute over the proper role of the organization. C. Ian Jackson, hired in 1981 as an outsider with a new vision for the 101-year-old honorary society, was asked to leave June 19 by the organization's board of directors. The board was scheduled to meet last weekend to discuss plans for choosing his successor. "I am not leaving voluntarily," Jackso

Written bySeth Shulman
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

C. Ian Jackson, hired in 1981 as an outsider with a new vision for the 101-year-old honorary society, was asked to leave June 19 by the organization's board of directors. The board was scheduled to meet last weekend to discuss plans for choosing his successor.

"I am not leaving voluntarily," Jackson asserted in an interview from his home in New Haven, Conn., the headquarters of the society. "I would have liked to stay on and complete some of the changes that have begun, but I don't want to make more controversy than already exists."

Although his departure appears to be the result of a major ideological battle over the direction the society should take, insiders also portray it as the culmination of problems caused by Jackson's management style.

Klaus Timmerhaus, a chemical engineer at the University of Colorado at Boulder and incoming president of the society, called the current situation ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies